home / stock / torc / torc short
Short Information | resTORbio Inc. (NASDAQ:TORC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,076,420 |
Total Actual Volume | 6,788,417 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 53,821 |
Average Short Percentage | 16.34% |
Is there a TORC Short Squeeze or Breakout about to happen?
See the TORC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-15-2020 | $2.38 | $2.28 | $2.46 | $2.21 | 850,283 | 130,868 | 15.39% |
09-14-2020 | $2.14 | $2.37 | $2.39 | $2.14 | 712,328 | 65,779 | 9.23% |
09-11-2020 | $2.13 | $2.15 | $2.19 | $2.06 | 211,501 | 33,538 | 15.86% |
09-10-2020 | $2.11 | $2.11 | $2.18 | $2.03 | 171,517 | 49,035 | 28.59% |
09-09-2020 | $2 | $2.09 | $2.15 | $2 | 229,857 | 32,687 | 14.22% |
09-08-2020 | $2 | $1.97 | $2.06 | $1.92 | 221,406 | 37,822 | 17.08% |
09-04-2020 | $2.06 | $2 | $2.08 | $1.882 | 453,541 | 59,218 | 13.06% |
09-03-2020 | $2.18 | $2.08 | $2.2 | $2.045 | 240,002 | 39,824 | 16.59% |
09-02-2020 | $2.12 | $2.17 | $2.2 | $2.09 | 186,467 | 45,392 | 24.34% |
09-01-2020 | $2.29 | $2.13 | $2.3 | $2.1 | 278,186 | 33,393 | 12% |
08-31-2020 | $2.05 | $2.28 | $2.3 | $2.05 | 605,573 | 154,056 | 25.44% |
08-28-2020 | $2.03 | $2.05 | $2.13 | $2.03 | 244,363 | 62,253 | 25.48% |
08-27-2020 | $2.16 | $2.05 | $2.1792 | $2.02 | 151,733 | 23,173 | 15.27% |
08-26-2020 | $2.06 | $2.15 | $2.21 | $2.02 | 211,264 | 25,899 | 12.26% |
08-25-2020 | $2.03 | $2.05 | $2.11 | $2.02 | 314,847 | 30,366 | 9.64% |
08-24-2020 | $2.17 | $2.08 | $2.18 | $2.02 | 510,825 | 104,118 | 20.38% |
08-21-2020 | $2.3 | $2.19 | $2.34 | $2.14 | 313,353 | 41,795 | 13.34% |
08-20-2020 | $2.15 | $2.27 | $2.3 | $2.15 | 246,874 | 22,772 | 9.22% |
08-19-2020 | $2.23 | $2.17 | $2.29 | $2.16 | 387,429 | 32,552 | 8.4% |
08-18-2020 | $2.28 | $2.23 | $2.36 | $2.23 | 247,068 | 51,880 | 21% |
News, Short Squeeze, Breakout and More Instantly...
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -...
MENLO PARK, Calif. , Aug. 5, 2020 /PRNewswire/ -- Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the t...
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today provided a corporate update and reported financial results ...